Immunological hyperresponsiveness in HTLV-I LTR-env-pX transgenic rats: A prototype animal model for collagen vascular and HTLV-I-related inflammatory diseases

Pathobiology

Volumn 69, Issue 1, 2001, Pages 11-18

  Nakamaru, Yuji ^a   Ishizu, Akihiro ^a   Ikeda, Hitoshi ^a   Sugaya, Toshiaki ^a   Fugo, Kazunori ^a   Higuchi, Masato ^a   Yamazaki, Hidetoshi ^a   Yoshiki, Takashi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal model; Collagen vascular disease; HTLV I; Transgenic rat

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; MITOGENIC AGENT; MONOCLONAL ANTIBODY CD3; SUPERANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; COLLAGEN DISEASE; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATORY DISEASE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL COUNT; COLLAGEN DISEASES; DISEASE MODELS, ANIMAL; GENES, ENV; GENES, PX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE GLYCOPROTEINS; MYOCARDITIS; RATS; T-LYMPHOCYTES; VASCULITIS;

ANIMALIA; HTLV; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0034779459     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048752     Document Type: Article

References (45)

1. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
2. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease
3. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis
4. HTLV-I associated myelopathy, a new clinical entity
5. Chronic inflammatory arthropathy associated with HTLV-I
6. HTLV-I uveitis: A distinct clinical entity caused by HTLV-I
7. T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome
8. Infective dermatitis of Jamaican children: A marker for HTLV-I infection
9. T-lymphocyte alveolitis in HTLV-I-associated myelopathy
10. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus
11. Downregulation of IL-10 secretion and enhanced antigen-presenting abilities following HTLV-I infection of T cells
12. Infiltration of helper/inducer T cells and activated T cells in HTLV-I-associated myelopathy
13. Immunological findings in neurologic diseases associated with antibodies to HTLV-I activated lymphocytes in tropical spastic paraparesis
14. A rat model of HTLV-I infection
15. A rat model of HTLV-I infection. I. Humoral antibody response, provirus integration and HAM/TSP-like myelopathy in seronegative HTLV-I carrier rats
16. A rat model of HTLV-I infection: Development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis
17. Human T lymphocyte virus type I-induced myeloneuropathy in rats: Implication of local activation of the pX and tumor necrosis factor-α genes in pathogenesis
18. A rat model of human T lymphocyte virus type I (HTLV-I) infection: In situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy
19. A rat model for human T lymphocyte virus type I-associated myeloneuropathy. Down-regulation of bcl-2 expression and increase in sensitivity to TNF-alpha of the spinal oligodendrocytes
20. Human T-lymphocytic virus type I (HTLV-I)-induced myeloneuropathy in rats: Oligoden-drocytes undergo apoptosis in the presence of HTLV-I
21. Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I
22. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I
23. Promotion of early osteogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type I
24. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction
25. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1 and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocyte to high endothelial cells
26. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
27. Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans
28. Functional activation of long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor
29. Regulation of human interleukin-2 gene: Functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes
30. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotype
31. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression
32. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony stimulating factor gene through a common DNA element
33. Trans activation of the tumor necrosis factor alpha promoter by the human T-cell leukemia virus type I Tax1 protein
34. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1
35. Transactivation of the transforming growth factor β1 (TGF-β1) gene by human T lymphotropic virus type 1 tax: A potential mechanism for the increased production of TGF-β1 in adult T cell leukemia
36. Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-I tax protein
37. HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences
38. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-I-transformed T cells
39. Induction of ICAM-1 and LFA-3 by tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines
40. Adhesion receptors of the immune system
41. B70 antigen is a second ligand for CTLA-4 and CD28
42. Cloning of B7-2: A CTLA-4 counter receptor that co-stimulates human T cell proliferation
43. Functional expression of B7/BB1 on activated T lymphocytes
44. Non-specifically activated human peripheral blood mononuclear cells are cytotoxic for human keratinocytes in vitro
45. Lysis of keratinocytes by IL-2-activated peripheral blood lymphocytes